摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5-二叔丁基-4-羟基苯甲腈 | 1988-88-1

中文名称
3,5-二叔丁基-4-羟基苯甲腈
中文别名
3,5-二-叔-丁基-4-羟基苯甲腈
英文名称
2,6-di-tert-butyl-4-cyanophenol
英文别名
3,5-Di-tert-butyl-4-hydroxybenzonitrile;3,5-ditert-butyl-4-hydroxybenzonitrile
3,5-二叔丁基-4-羟基苯甲腈化学式
CAS
1988-88-1
化学式
C15H21NO
mdl
MFCD00156137
分子量
231.338
InChiKey
AKXIIOLURNATOC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    144 °C
  • 稳定性/保质期:
    如果按照规定使用和储存,则不会发生分解,目前没有已知的危险反应,应避免接触氧化物。

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.533
  • 拓扑面积:
    44
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险等级:
    6.1
  • 危险品标志:
    Xn
  • 安全说明:
    S26,S36/37/39,S45
  • 危险类别码:
    R20/21/22,R36/37/38
  • 海关编码:
    2926909090
  • 包装等级:
    III
  • 危险类别:
    6.1
  • 危险品运输编号:
    3276
  • 储存条件:
    请将贮藏器保持密封状态,并存放在阴凉、干燥处。同时,确保工作环境具有良好的通风或排气设施。

SDS

SDS:988b6cecfa9485bc8ebfc550addee134
查看
Name: 3 5-Di(tert-butyl)-4-hydroxybenzonitrile 97% Material Safety Data Sheet
Synonym:
CAS: 1988-88-1
Section 1 - Chemical Product MSDS Name:3 5-Di(tert-butyl)-4-hydroxybenzonitrile 97% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
1988-88-1 3,5-Di(tert-butyl)-4-hydroxybenzonitri 97% unlisted
Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 1988-88-1: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 141 - 143 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C15H21NO
Molecular Weight: 231

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Acids, bases, oxidizing agents.
Hazardous Decomposition Products:
Hydrogen cyanide, nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 1988-88-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3,5-Di(tert-butyl)-4-hydroxybenzonitrile - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: NITRILES, SOLID, TOXIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
IMO
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
RID/ADR
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 1988-88-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 1988-88-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1988-88-1 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A



上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    3,5-二叔丁基-4-羟基苯甲腈 以50%的产率得到2,6-Bis(1,1-dimethylethyl)-4-(3,4,8,9-tetrahydro-6-methoxy-3,3,8,8-tetramethylfuro[2,3-h]isoquinolin-1-yl)phenol hydrochloride
    参考文献:
    名称:
    FUROISOQUINOLINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF
    摘要:
    公开号:
    EP1270577B1
  • 作为产物:
    描述:
    参考文献:
    名称:
    Rearrangement fragmentation of aldoxime to isocyanide
    摘要:
    DOI:
    10.1007/bf01457806
  • 作为试剂:
    描述:
    三氯乙腈 在 aluminum tri-bromide 、 3,5-二叔丁基-4-羟基苯甲腈 作用下, 以 乙醚 为溶剂, 以27%的产率得到6-<3,5-di(tert-butyl)-4-hydroxyphenyl>-2,4-bis(trichloromethyl)-sym-trazene
    参考文献:
    名称:
    Synthesis and properties of sym-triazine derivatives. 8. Synthesis of amino and alkoxy derivatives of sym-triazine containing fragments of a sterically-hindered phenol from 2,4-bis(trichloromethyl)-sym-triazines
    摘要:
    DOI:
    10.1007/bf00755699
点击查看最新优质反应信息

文献信息

  • Crystal Engineering and Substituent Effect of Hindered Phenols for SHG Materials
    作者:Koichi Takagi、Akira Mizuno、Michiru Kubata、Akira Mizoguchi、Masaru Furushow、Masaru Matsuoka
    DOI:10.1246/cl.1992.1743
    日期:1992.9
    2,6-Di-tert-butylphenol moiety was found to be effective to control molecular packing in crystals for SHG materials. Many derivatives having compact acceptor group at 4-position of hindered phenols showed SHG responses depending on the electron withdrawing effect of an acceptor. The X-ray structural analyses revealed that molecular packing was controlled both by the steric requirements and the intermolecular hydrogen bonding.
    研究发现,含有2,6-二叔丁基苯酚部分的化合物能够有效控制SHG材料的晶体分子堆积。许多在受阻酚4位具有紧凑受体基团的衍生物,其SHG响应取决于受体的吸电子效应。X射线结构分析揭示,分子堆积既受到空间位阻要求的控制,也受到分子间氢键的影响。
  • Reaction of superoxo Co(III) complex with stable phenoxy radicals
    作者:A. Nishinaga、H. Tomita、T. Matsuura
    DOI:10.1016/s0040-4039(00)78701-6
    日期:1980.1
    A typical superoxo complex [Co(CN)5O2][Ph3PNPPh3]3 combines with stable phenoxy radicals in CH2Cl2 leading to selective formation of peroxy--quinols except for 2,4,6-tri--butylphenoxy radical, representing radical reactivity of the complex.
    一个典型的复杂superoxo [CO(CN)5 ö 2 ] [PH 3 PNPPh 3 ] 3个结合在CH稳定的苯氧自由基2氯2导致过氧的选择性形成-quinols除了2,4,6-三---丁基苯氧基自由基,代表配合物的自由基反应性。
  • Oxidation of 2,6-di-tert-butylphenol by tetrapyridyl oxoiron(IV) complex
    作者:Dóra Lakk-Bogáth、Gábor Speier、József Kaizer
    DOI:10.1016/j.poly.2018.02.015
    日期:2018.5
    (S = 1) oxoiron(IV) complex, [FeIV(O)(asN4Py)] (2) (asN4Py = N,N-bis(2-pyridylmethyl)-1,2-di(2-pyridyl)ethylamine), has been investigated in the oxidation reaction of 2,6-di-tert-butylphenol derivatives. Detailed kinetic, and mechanistic studies (kinetic isotope effect (KIE) of 4.52, and Hammett correlation with ρ = −1.83), lead to the conclusion that the rate-determining step in this reaction involves direct
    摘要先前报道的五齿低自旋(S = 1)氧化铁(IV)配合物[FeIV(O)(asN4Py)](2)(asN4Py = N,N-双(2-吡啶基甲基)-1,已经研究了2-二(2-吡啶基)乙胺在2,6-二叔丁基苯酚衍生物的氧化反应中。详细的动力学和机理研究(动力学同位素效应(KIE)为4.52,Hammett相关系数为ρ= −1.83)得出结论,该反应的速率确定步骤涉及氢原子直接转移(HAT)。与血红素型辣根过氧化物酶(HRP)系统相反,氧代铁(IV)物种产生了苯酚。
  • Phenol Oxidation by a Nickel(III)–Fluoride Complex: Exploring the Influence of the Proton Accepting Ligand in PCET Oxidation
    作者:Prasenjit Mondal、Aidan R. McDonald
    DOI:10.1002/chem.202002135
    日期:2020.8.6
    transfer/electron transfer (PT/ET) reaction mechanism. The analogous complexes [NiIII(Z)(L)] (Z=Cl, OCO2H, O2CCH3, ONO2) reacted with all phenols through a HAT mechanism. We explore the reason for a change in mechanism with the highly basic fluoride ligand in 2 . Complex 2 was also found to react one to two orders of magnitude faster than the corresponding analogous [NiIII(Z)(L)] complexes. This was ascribed
    为了深入了解H +受体末端配体在高价氧化剂介导的质子偶联电子传递(PCET)反应中的影响,使用了高价氟化镍络合物的反应性[Ni III(F)(L) ](2,L = N,N'-(2,6-二甲基苯基)-2,6-吡啶氨基甲酸酯)的研究。对这些反应的动力学数据(Evans-Polanyi,Hammett和Marcus图以及KIE测量)和形成的产物进行分析,结果表明2与富电子酚通过氢原子转移(HAT或PCET协同作用)机理以及与电子反应通过逐步质子转移/电子转移(PT / ET)反应机理获得的不良酚。类似物[Ni III(Z)(L)](Z = Cl,OCO 2 H,O 2 CCH 3,ONO 2)通过HAT机理与所有酚反应。我们探索了在2中具有高碱性氟化物配体的机理发生变化的原因。还发现,配合物2的反应比相应的类似[Ni III(Z)(L)]配合物快一到两个数量级。这归因于与HF相关的高键解离自由能值(135
  • Synthesis and pharmacological evaluation of imidazoline sites I1 and I2 selective ligands
    作者:Maria Anastassiadou、Saı̈da Danoun、Louis Crane、Geneviève Baziard-Mouysset、Marc Payard、Daniel-Henri Caignard、Marie-Claire Rettori、Pierre Renard
    DOI:10.1016/s0968-0896(00)00280-7
    日期:2001.3
    heterocyclic-imidazoline compounds have been prepared and evaluated in vitro as imidazoline sites (I1 and I2) and alpha-adrenergic (alpha1 and alpha2) receptor ligands. Their pKi values indicate that linkage of the imidazoline moiety at the 2-position with an aromatic substituent dramatically decreases alpha-adrenergic affinity. I1 sites are more accessible by phenyl imidazolines substituted by a methyl or a methoxy
    已经制备了几种系列的2-芳基或杂环-咪唑啉化合物,并在体外评估为咪唑啉位点(I1和I2)和α-肾上腺素能(α1和α2)受体配体。它们的pKi值表明2-位咪唑啉部分与芳族取代基的连接显着降低了α-肾上腺素的亲和力。通过在邻位或间位上被甲基或甲氧基取代的苯基咪唑啉更易于接近I1位点。实际上,2-(2'-甲氧基苯基)-咪唑啉(17)是有史以来最好的I1配体之一(pKi = 8.53,I1 / I2> 3388)。另一方面,在对位中存在甲基时,I 2选择性增加。原始化合物2-(3'-氟-4'-甲苯基)-咪唑啉(31)是I2位点的新有效配体,具有高选择性(pKi = 8。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
cnmr
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐